By studying the gaze of experts as they assess images of the eye, data scientist Kaveri Thakoor has improved AI methods for glaucoma detection and developed a new way to instruct trainees.
Columbia genome engineers are designing a CRISPR-based gene therapy with potential to prevent blindness in anyone with retinitis pigmentosa, a condition caused by more than 80 different genes.
Most people are familiar with melanoma as a skin cancer, but melanoma can impact the eyes as well. Brian Marr, MD, offers tips on how to protect your eyes.
New genetic findings should help researchers uncover how MacTel, a disease of the retina, develops and how to design therapies to prevent loss of vision.
Columbia University researchers slowed vision loss in mice who have a form of retinitis pigmentosa by reprogramming the metabolism of photoreceptors in the retina.
Columbia University Medical Center researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa, a leading cause of vision loss.
Dr. Janet Sparrow and colleagues are pioneering a new way to use the retina's natural fluorescence to track and characterize the progression of eye diseases.